| 产品描述: | BML-280 (VU0285655-1) 是一种有效的选择性磷脂酶 D2 (PLD2) 抑制剂。BML-280 能够防止高糖诱导的 caspase-3 裂解和细胞活力降低。BML-280 可用于类风湿关节炎的研究。 |
| 靶点: |
PLD2;PLD1 |
| 体外研究: |
BML-280 shows an approximately 21-fold selectivity for PLD2. BML-280 (0-0.1 µM) suppresses formyl-Met-Leu-Phe (fMLP)-stimulated PLD activity in a concentration dependent manner, with an IC50 of 0.04 ± 0.01 μM. BML-280 (0-0.3 µM) inhibits O2- generation, and the inhibition reaches a plateau (about 20 % inhibition) at around 0.01 μM to 0.3 μM. BML-280 (0-5 µM, 24 h) reduces proliferation in PLD1-deficient cells, but also in PLD2-deficient cells exposed to IGF-1 (Insulin-like growth factor 1). BML-280 inhibits mRNA levels and secretion of tumor necrosis factor-α, IL-1β and IL-8 in human periodontal ligament cells. |
| 参考文献: |
1. Burkhardt U, et al. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion. Eur J Pharmacol. 2015 Aug 15;761:398-404.
2. Tenconi PE, et al. High glucose-induced phospholipase D activity in retinal pigment epithelium cells: New insights into the molecular mechanisms of diabetic retinopathy. Exp Eye Res. 2019 Jul;184:243-257.
3. Tsai YR, et al. Inhibition of formyl peptide-stimulated phospholipase D activation by Fal-002-2 via blockade of the Arf6, RhoA and protein kinase C signaling pathways in rat neutrophils. Naunyn Schmiedebergs Arch Pharmacol. 2013 Jun;386(6):507-19. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.151 ml |
10.753 ml |
21.506 ml |
| 5 mM |
0.43 ml |
2.151 ml |
4.301 ml |
| 10 mM |
0.215 ml |
1.075 ml |
2.151 ml |
| 50 mM |
0.043 ml |
0.215 ml |
0.43 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |